Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.76 |
| ▸ | MAPT | P10636 | 3/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.76 |
| ▸ | LMNA | P02545 | 2/20 | 0.76 |
| ▸ | TSHR | P16473 | 2/20 | 0.76 |
| ▸ | BLM | P54132 | 2/20 | 0.76 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | MPO | P05164 | 1/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.76 |
| ▸ | APAF1 | O14727 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 3/20 | 0.56 |
| ▸ | HTR1A | P08908 | 2/20 | 0.56 |
| ▸ | HTR2C | P28335 | 2/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.56 |
| ▸ | HTR7 | P34969 | 2/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL2060360 | 1.00 | KDM4E (0.76) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL20504023 | 0.97 | KDM4E (0.71) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL3857030 | 0.96 | KDM4E (0.70) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL29183929 | 0.94 | KDM4E (0.68) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL18249969 | 0.94 | KDM4E (0.68) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL28202459 | 0.93 | KDM4E (0.65) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL22635845 | 0.92 | KDM4E (0.64) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL5315679 | 0.91 | KDM4E (0.63) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL7267888 | 0.91 | KDM4E (0.63) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL9617704 | 0.91 | KDM4E (0.63) | KDM4EMAPTKMT2ALMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105134-A1 | C-Terminally Pegylated Growth Hormones | NOVO NORDISK A/S (DK) | 2009-04-23 | — | — | US | claimed |
| US-20030104389-A1 | Synthesis of biologically active compounds in cells | SERGEEV PAVEL (CH) | 2003-06-05 | — | — | US | claimed |
| EP-1208219-A1 | SYNTHESIS OF BIOLOGICALLY ACTIVE COMPOUNDS IN CELLS | Sergeev, Pavel (CH) | 2002-05-29 | — | — | EP | claimed |
| WO-2000061775-A1 | SYNTHESIS OF BIOLOGICALLY ACTIVE COMPOUNDS IN CELLS | SERGEEV PAVEL (CH) | 2000-10-19 | — | — | WO | claimed |
| CN-111386050-B | Morbidity risk assessment device, morbidity risk assessment method, and computer-readable medium | 国立大学法人九州大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-116536191-A | L-theanine faecal bacteria liquid and preparation method and application thereof | 湖南农业大学 | 2023-08-04 | — | — | CN | disclosed |
| CN-113397056-A | Feed for improving lean meat percentage of piglets and preparation method and application thereof | 长春禾丰饲料有限责任公司 | 2021-09-17 | — | — | CN | disclosed |
| CN-111386050-A | Disease risk evaluation device, disease risk evaluation method, program, and dementia prevention food | 国立大学法人九州大学 | 2020-07-07 | — | — | CN | disclosed |
| US-20190145962-A1 | PEPTIDE FOR INHIBITING BINDING OF AMYLOSPHEROIDS (ASPD), AND EVALUATION AND SCREENING METHOD | TAO HEALTH LIFE PHARMA CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| CN-109706133-A | One group of novel esterases and its application | 上海交通大学 | 2019-05-03 | — | — | CN | disclosed |
| US-8795734-B2 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-08-05 | — | — | US | disclosed |
| US-20130034610-A1 | HYDROPHOBIC NANOTUBES AND NANOPARTICLES AS TRANSPORTERS FOR THE DELIVERY OF DRUGS INTO CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-02-07 | — | — | US | disclosed |
| US-8246995-B2 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-08-21 | — | — | US | disclosed |
| US-7459443-B2 | Oligonucleotide sequences for use as viricide or antitumor agents; biosynthesis | SERGEEV PAVEL | 2008-12-02 | — | — | US | disclosed |
| US-20060275371-A1 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | UNIVERSITY, STANFORD | 2006-12-07 | — | — | US | disclosed |
| US-20050026143-A1 | Synthesis of biologically active compounds in cells | SERGEEV PAVEL (CH) | 2005-02-03 | — | — | US | disclosed |
| US-6831071-B2 | Oligonucleotide sequences for use as viricide or antitumor agents | SERGEEV PAVEL (CH) | 2004-12-14 | — | — | US | disclosed |
| WO-2004080920-A1 | HYDROPONIC PLANT NUTRIENT KIT AND METHOD OF USE | ADVANCED NUTRIENTS LTD. (CA) | 2004-09-23 | — | — | WO | disclosed |
| US-20030104389-A1 | Synthesis of biologically active compounds in cells | SERGEEV PAVEL (CH) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105134-A1 | C-Terminally Pegylated Growth Hormones | GHRHR, GHITM, HDGF | KDM4E 4141/4885MAPT 3647/4885KMT2A 3669/4885 |
| US-20050026143-A1 | Synthesis of biologically active compounds in cells | FBL, RNGTT, NOP2 | KDM4E 4491/4885MAPT 4003/4885KMT2A 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.